European Equities Traded in the US as American Depositary Receipts Rise Friday

MT Newswires Live
Yesterday

European equities traded in the US as American depositary receipts were higher late Friday morning, rising 0.78% to 1,826.25 on the S&P Europe Select ADR Index, which is up 1.3% for the week so far.

From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and biotech firm Evaxion (EVAX), which rose 4.7% and 4.4% respectively. They were followed by oil and gas company Eni (E) and lender Banco Bilbao Vizcaya Argentaria (BBVA), which increased 2.6% and 2.5% respectively.

The decliners from continental Europe were led by software firm SAP (SAP) and semiconductor firm Sequans Communications (SQNS), which fell 1.6% and 1.2% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and internet browser company Opera (OPRA), which were off 1% and 0.9% respectively.

The gainers from the UK were led by Lloyds Banking Group (LYG), which rose 3%. It was followed by telecommunications operator Vodafone Group (VOD) and InterContinental Hotels Group (IHG), which were up 2.7% and 2.6% respectively.

The decliners from the UK and Ireland were led by Biodexa Pharmaceuticals (BDRX) and educational publisher Pearson (PSO), which lost 4.9% and 1.5% respectively. They were followed by medical device maker Smith & Nephew (SNN) and software company Endava (DAVA), which fell 1.3% and 1.2% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10